Fondazione del Piemonte per l'Oncologia IRCCS Candiolo

Candiolo, Torino 10060

1 studies enrolling now · 2 studies all time

What they study most

Secondary Immune Deficiency, Urothelial Cancer

Studies at this site

• Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies — Starting soon
• A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100) — Completed